2P16.3 (NRXN1) deletion New Family Based Study
Relative Diversity associated with Neurexin Trajectories – The RaDiaNT study
Project Lead: Prof. Louise Gallagher
We are currently recruiting for our new study that aims to understand mental health in family members with and without 2P16.3 (NRXN1) deletion.
We are recruiting families who have at least one person with 2P16.3 (NRXN1) deletion.
We are working with research teams in Toronto, Canada and Melbourne Australia to build the largest 2P16.3 (NRXN1) deletion research dataset.
This study is part of an international consortium called the R2D2-MH consortium, which includes 25 partners around the world who are doing different research studies to better understand mental health associated with neurodevelopmental diversity. Follow this link to learn more about R2D2-MH: Risk and resilience in developmental diversities - R2D2-MH
If you are interested in joining our study or finding out more email us at: recruitmentNRG@tcd.ie
If you take part in this study you will be asked to:
- Provide a blood/saliva samples
- Fill out questionnaires
- Complete interviews
The following will be completed at the neurocognition lab at Trinity Centre for Health Sciences
- Play games on a tablet
- Complete pen and paper tasks